Time-course effects of St John's wort on the pharmacokinetics of cyclosporine in dogs

被引:13
|
作者
Fukunaga, K. [1 ]
Orito, K. [1 ]
机构
[1] Azabu Univ, Sch Vet Med, Dept Physiol 2, Sagamihara, Kanagawa 2525201, Japan
关键词
A PHARMACOKINETICS; DRUG-METABOLISM; P-GLYCOPROTEIN; INDUCTION; DIGOXIN; EXTRACT;
D O I
10.1111/j.1365-2885.2011.01348.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Fukunaga, K., Orito, K. Time-course effects of St Johns wort on the pharmacokinetics of cyclosporine in dogs. J. vet. Pharmacol. Therap. 35, 446-451. To clarify the interaction between St Johns wort (SJW) and cyclosporine (CsA) in dogs, the pharmacokinetics of CsA before and during the repeated administration of SJW were analyzed. In the SJW group, SJW (300 mg) was given orally to four dogs every 24 h for 14 days. A single dose of CsA (5 mg/kg) was given orally 7 days before and 7 and 14 days after the initiation of the repeated administration of SJW. In the Control group, a single dose of CsA (5 mg/kg) was given orally to four other dogs in accordance with that in the SJW group. Blood samples from both groups were collected, and whole-blood concentrations of CsA were determined using high-performance liquid chromatography with UV detection. The maximum whole-blood concentration and AUC08 of the SJW group were significantly lower and the CLtot/F and Vd/F were significantly higher than those in the Control group 7 and 14 days after the initiation of repeated SJW. Thus, repeated administrations of SJW affect the pharmacokinetic profiles of CsA in dogs. Further studies are necessary to elucidate the mechanisms of interaction between SJW and CsA in dogs.
引用
收藏
页码:446 / 451
页数:6
相关论文
共 50 条
  • [41] Inhibition of pancreatic lipase by the constituents in St. John's Wort: In vitro and in silico investigations
    Hou, Xu-Dong
    Guan, Xiao-Qing
    Cao, Yun-Feng
    Weng, Zi-Miao
    Hu, Qing
    Liu, Hai-Bin
    Jia, Shou-Ning
    Zang, Shi-Zhu
    Zhou, Qi
    Yang, Ling
    Ge, Guang-Bo
    Hou, Jie
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 145 (145) : 620 - 633
  • [42] Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis
    Ng, Qin Xiang
    Venkatanarayanan, Nandini
    Ho, Collin Yih Xian
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 210 : 211 - 221
  • [43] Effects of treatment with St. John's Wort on blood glucose levels and pain perceptions of streptozotocin-diabetic rats
    Can, Ozgur Devrim
    Ozturk, Yusuf
    Ozturk, Nilgun
    Sagratini, Gianni
    Ricciutelli, Massimo
    Vittori, Sauro
    Maggi, Filippo
    FITOTERAPIA, 2011, 82 (04) : 576 - 584
  • [44] Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical Observations
    Francesca Borrelli
    Angelo A. Izzo
    The AAPS Journal, 2009, 11 : 710 - 727
  • [45] St. John's wort (Hypericum perforatum L.) and kindling epilepsy in rabbit
    Ivetic, V
    Popovic, M
    Mimica-Dukic, N
    Barak, O
    Pilija, V
    PHYTOMEDICINE, 2002, 9 (06) : 496 - 499
  • [46] Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence
    Izzo, AA
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2004, 42 (03) : 139 - 148
  • [47] St John's Wort increases expression of P-glycoprotein: Implications for drug interactions
    Hennessy, M
    Kelleher, D
    Spiers, JP
    Barry, M
    Kavanagh, P
    Back, D
    Mulcahy, F
    Feely, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (01) : 75 - 82
  • [48] Usefulness of studies on the molecular mechanism of action of herbals/botanicals: The case of St. John's Wort
    Choudhuri, S
    Valerio, LG
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2005, 19 (01) : 1 - 11
  • [49] St. John's Wort accelerates the liver clearance of technetium-99-sestamibi in rats
    Mohammadinia, Salam
    Abedi, Seyed M.
    Noaparast, Zohreh
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (09) : 839 - 844
  • [50] Subchronic treatment with St John's wort produces a positive shift in emotional processing in healthy volunteers
    Warren, Matthew B.
    Cowen, Philip J.
    Harmer, Catherine J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (02) : 194 - 201